Greenwings Biomedical, Inc.

  • Home
  • Greenwings Biomedical, Inc.

Greenwings Biomedical, Inc. We translate exceptional biomedical innovation into exceptional ventures

Our mission is to translate intellectual property invented at university research labs into FDA-cleared, commercial-ready medical solutions that we either launch commercially or sell to established companies. Our goal is to significantly improve the cost and quality of healthcare by advancing clinician productivity, clinical decision support, personalized medicine, non-invasive therapy, coordination of care, and patient management and engagement. Our focus is on clinical decision support systems, biomedical devices and digital-health products enabled at their core by highly innovative algorithms and software-based intelligence.

19/08/2013

In five weeks from now, the Patient Protection and Affordable Care Act (ACA) mandates the opening of health insurance exchanges around the country. At that time New Yorkers will be introduced to an innovative way of thinking about health care: Oscar. Three friends, and technology entrepreneurs, team...

13/08/2013

"The question is, at what point is selling expensive stand-alone products no longer tenable? At least some executives are clearly beginning to worry that this time may be fast-approaching."

The question is, at what point is selling expensive stand-alone products no longer tenable? At least some executives are clearly beginning to worry that this time may be fast-approaching.

06/08/2013

Prices inevitably drop when consumers are given leverage to shop for prices.

Joint replacement prices at the most costly California hospitals plunged by one-third after the state required its workers and retirees to pay out of pocket all costs above a “reference price” of $30,000 for orthopedic surgery, a new study said.

The medical device industry is being ravaged by unwise public policy, including a devastating 2.3% excise tax took effec...
25/07/2013

The medical device industry is being ravaged by unwise public policy, including a devastating 2.3% excise tax took effect on Jan 1 as part of ObamaCare.

The medical device industry is being ravaged by unwise public policy, including a devastating 2.3% excise tax took effect on Jan 1 as part of ObamaCare.

24/07/2013

EvoTech is developing an endoscope called the EvoCam that is substantially equivalent in terms of functionality, but costs a fraction of comparable devices.

22/07/2013

American Medical Association committee exaggerates time of procedures, Post investigation finds

Address


Alerts

Be the first to know and let us send you an email when Greenwings Biomedical, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram